Name | JNJ-4355 |
---|
Description | JNJ-4355 is a highly potent MCL-1 (myeloid cell leukemia-1) inhibitor, with KI of 18 pM. JNJ-4355 shows antitumor activity[1][2]. |
---|---|
Related Catalog | |
Target |
Mcl-1:18 pM (Ki) |
In Vitro | JNJ-4355 shows promising in vitro potency data in cancer cell lines and AML patient-derived samples[2]. |
In Vivo | JNJ-4355 (IV , single) shows complete tumor regression in a mouse MOLP8 (multiple myeloma) xenograft[2]. |
References |
Molecular Formula | C40H43ClFN5O5S |
---|---|
Molecular Weight | 760.32 |